Identification of transcriptome signature for myocardial reductive stress

Redox Biology
Justin M QuilesNamakkal S Rajasekaran


The nuclear factor erythroid 2 like 2 (Nfe2l2/Nrf2) is a master regulator of antioxidant gene transcription. We recently identified that constitutive activation of Nrf2 (CaNrf2) caused reductive stress (RS) in the myocardium. Here we investigate how chronic Nrf2 activation alters myocardial mRNA transcriptome in the hearts of CaNrf2 transgenic (TG-low and TG-high) mice using an unbiased integrated systems approach and next generation RNA sequencing followed by qRT-PCR methods. A total of 246 and 1031 differentially expressed genes (DEGs) were identified in the heart of TGL and TGH in relation to NTG littermates at ~ 6 months of age. Notably, the expression and validation of the transcripts were gene-dosage dependent and statistically significant. Ingenuity Pathway Analysis identified enriched biological processes and canonical pathways associated with myocardial RS in the CaNrf2-TG mice. In addition, an overrepresentation of xenobiotic metabolic signaling, glutathione-mediated detoxification, unfolded protein response, and protein ubiquitination was observed. Other, non-canonical signaling pathways identified include: eNOS, integrin-linked kinase, glucocorticoid receptor, PI3/AKT, actin cytoskeleton, cardiac hypertrophy, and th...Continue Reading


Mar 23, 2000·Cardiovascular Research·Stefan HeinJutta Schaper
Sep 26, 2000·Molecular and Cellular Biology·S J CharetteJ Landry
Jan 5, 2002·Physiological Reviews·Wulf Dröge
Jun 11, 2002·Biochemical and Biophysical Research Communications·Oliver ZolkThomas Eschenhagen
Aug 17, 2002·Science·Eunkyung LeePietro De Camilli
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Moon-Il KangMasayuki Yamamoto
Aug 4, 2004·Circulation·Penny M Kris-EthertonNutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism
Feb 12, 2005·Antioxidants & Redox Signaling·Makoto Kobayashi, Masayuki Yamamoto
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
May 27, 2006·Cell Death and Differentiation·P Pinton, R Rizzuto
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
Mar 3, 2007·The Journal of Clinical Investigation·Bradford C BerkStephanie Lehoux
Apr 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sudeshna FischMukesh K Jain
Jul 28, 2007·Journal of Molecular and Cellular Cardiology·Christine ChiuChristopher Semsarian
Jul 1, 2008·Journal of Molecular and Cellular Cardiology·Baiqiu WangMukesh K Jain
Mar 20, 2009·Cell Motility and the Cytoskeleton·Davina TondeleirAnja Lambrechts
Nov 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yvonne S YangStephen M Strittmatter
Jan 26, 2010·Mutation Research·Ornella CazzaliniEnnio Prosperi
Feb 20, 2010·PLoS Biology·TingTing HongRobin M Shaw
Apr 9, 2010·Science Translational Medicine·Saptarsi M HaldarMukesh K Jain
Aug 3, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Vijay KandalamZamaneh Kassiri
Nov 3, 2010·The Journal of Biological Chemistry·Marie-Cecile KienitzGeorg Zoidl
Jun 24, 2011·Science Translational Medicine·Gopinath SutendraEvangelos D Michelakis
Jan 17, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Qingzhong XiaoQingbo Xu
May 9, 2012·Disease Models & Mechanisms·Ellen DeesDavid M Bader
Sep 4, 2012·Antioxidants & Redox Signaling·Alison C BrewerIvor J Benjamin
Jan 3, 2013·The Journal of Clinical Investigation·Andrew R Marks
Sep 27, 2013·PLoS Genetics·Kira M Glover-CutterT Keith Blackwell
May 20, 2014·Nature Medicine·TingTing HongRobin M Shaw
Feb 7, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Yujia WangJiangping Wu
May 10, 2017·Redox Biology·Gobinath ShanmugamNamakkal S Rajasekaran


Feb 15, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Jessica M MillerRamaswamy Kannappan
Feb 18, 2020·Antioxidants & Redox Signaling·Gobinath ShanmugamRajasekaran Namakkal Soorappan
Feb 20, 2020·Cellular and Molecular Life Sciences : CMLS·Ilaria BellezzaRosario Donato
Jun 28, 2019·Frontiers in Cardiovascular Medicine·Gobinath ShanmugamNamakkal S Rajasekaran
Jul 21, 2020·Journal of Experimental Botany·John T Hancock, David Veal
Jun 23, 2020·Oxidative Medicine and Cellular Longevity·Wei-Xing MaLiang-Jun Yan
Aug 11, 2019·Ecotoxicology and Environmental Safety·Houjuan XingXiaohua Teng
Jun 9, 2021·Scientific Reports·Justin M QuilesNamakkal S Rajasekaran

Methods Mentioned

nuclear translocation
protein folding

Related Concepts

Related Feeds


Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.